A detailed history of American International Group, Inc. transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 20,217 shares of PMVP stock, worth $31,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,217
Previous 19,169 5.47%
Holding current value
$31,740
Previous $59,000 42.37%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.51 - $3.12 $1,582 - $3,269
1,048 Added 5.47%
20,217 $34,000
Q4 2023

Feb 13, 2024

SELL
$1.23 - $6.6 $95 - $514
-78 Reduced 0.41%
19,169 $59,000
Q3 2023

Nov 13, 2023

BUY
$6.01 - $8.93 $4,116 - $6,117
685 Added 3.69%
19,247 $118,000
Q2 2023

Aug 04, 2023

BUY
$3.94 - $6.27 $3,100 - $4,934
787 Added 4.43%
18,562 $116,000
Q1 2023

May 12, 2023

BUY
$4.77 - $9.16 $1,688 - $3,242
354 Added 2.03%
17,775 $84,000
Q4 2022

Feb 10, 2023

SELL
$8.17 - $12.95 $522 - $828
-64 Reduced 0.37%
17,421 $151,000
Q3 2022

Nov 14, 2022

BUY
$11.4 - $17.18 $2,827 - $4,260
248 Added 1.44%
17,485 $208,000
Q2 2022

Aug 12, 2022

BUY
$9.23 - $22.43 $38,895 - $94,520
4,214 Added 32.36%
17,237 $246,000
Q1 2022

May 13, 2022

SELL
$14.86 - $23.55 $13,611 - $21,571
-916 Reduced 6.57%
13,023 $271,000
Q4 2021

Feb 11, 2022

SELL
$19.99 - $30.24 $8,355 - $12,640
-418 Reduced 2.91%
13,939 $322,000
Q3 2021

Nov 12, 2021

SELL
$26.84 - $36.58 $9,152 - $12,473
-341 Reduced 2.32%
14,357 $428,000
Q2 2021

Aug 13, 2021

BUY
$28.01 - $36.01 $188,647 - $242,527
6,735 Added 84.58%
14,698 $502,000
Q1 2021

May 07, 2021

BUY
$30.66 - $49.5 $674 - $1,089
22 Added 0.28%
7,963 $262,000
Q4 2020

Feb 12, 2021

BUY
$31.86 - $61.51 $253,000 - $488,450
7,941 New
7,941 $488,000

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $71.6M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.